Literature DB >> 18999053

An adverse drug event and medication error reporting system for ambulatory care (MEADERS).

Atif Zafar1, John Hickner, Wilson Pace, William Tierney.   

Abstract

The Institute of Medicine (IOM) has identified the mitigation of Adverse Drug Events (ADEs) and Medication Errors (MEs) as top national priorities. Currently available reporting tools are fraught with inefficiencies that prevent widespread adoption into busy primary care practices. Using expert panel input we designed and built a new reporting tool that could be used in these settings with a variety of information technology capabilities. We pilot tested the system in four Practice Based Research Networks (PBRNs) comprising 24 practices. Over 10 weeks we recorded 507 reports, of which 200 were MEs, 116 ADEs and 68 were of other types. Clinicians found the system easy to use, with the average time to generating a report under 2 minutes. By using streamlined interface design techniques we were successfully able to improve reporting rates of ADEs and MEs in these practices.

Mesh:

Year:  2008        PMID: 18999053      PMCID: PMC2656098     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  13 in total

1.  Reporting of adverse events.

Authors:  Lucian L Leape
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

2.  Adverse drug event monitoring at the Food and Drug Administration.

Authors:  Syed Rizwanuddin Ahmad
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

3.  A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events.

Authors:  Carol Hope; J Marc Overhage; Andrew Seger; Evgenia Teal; Vera Mills; Julie Fiskio; Tejal K Gandhi; David W Bates; Michael D Murray
Journal:  J Biomed Inform       Date:  2003 Feb-Apr       Impact factor: 6.317

4.  Drug utilization in office visits to primary care physicians: National Ambulatory Medical Care Survey, 1980.

Authors:  B K Cypress
Journal:  Adv Data       Date:  1982-10-08

5.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

6.  Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

Authors:  A K Jha; G J Kuperman; J M Teich; L Leape; B Shea; E Rittenberg; E Burdick; D L Seger; M Vander Vliet; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

7.  Drug-related morbidity and mortality: updating the cost-of-illness model.

Authors:  F R Ernst; A J Grizzle
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

8.  Adverse drug events in ambulatory care.

Authors:  Tejal K Gandhi; Saul N Weingart; Joshua Borus; Andrew C Seger; Josh Peterson; Elisabeth Burdick; Diane L Seger; Kirstin Shu; Frank Federico; Lucian L Leape; David W Bates
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

9.  Drug complications in outpatients.

Authors:  T K Gandhi; H R Burstin; E F Cook; A L Puopolo; J S Haas; T A Brennan; D W Bates
Journal:  J Gen Intern Med       Date:  2000-03       Impact factor: 5.128

10.  Computerized surveillance of adverse drug events in hospital patients.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

View more
  5 in total

1.  Field test results of a new ambulatory care Medication Error and Adverse Drug Event Reporting System--MEADERS.

Authors:  John Hickner; Atif Zafar; Grace M Kuo; Lyle J Fagnan; Samuel N Forjuoh; Lyndee M Knox; John T Lynch; Brian Kelly Stevens; Wilson D Pace; Benjamin N Hamlin; Hilary Scherer; Brenda L Hudson; Caitlin Carroll Oppenheimer; William M Tierney
Journal:  Ann Fam Med       Date:  2010 Nov-Dec       Impact factor: 5.166

2.  Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial.

Authors:  Pierre Renaudin; Karine Baumstarck; Aurélie Daumas; Marie-Anne Esteve; Stéphane Gayet; Pascal Auquier; Michel Tsimaratos; Patrick Villani; Stéphane Honore
Journal:  Trials       Date:  2017-02-09       Impact factor: 2.279

3.  Using Electronic Health Records to Identify Adverse Drug Events in Ambulatory Care: A Systematic Review.

Authors:  Chenchen Feng; David Le; Allison B McCoy
Journal:  Appl Clin Inform       Date:  2019-02-20       Impact factor: 2.342

4.  The effect of different intensivist staffing patterns on the rate of potential drug-drug interactions in adult trauma intensive care units.

Authors:  Mansoor Masjedi; Mahtabalsadat Mirjalili; Ehsan Mirzaei; Hadis Mirzaee; Afsaneh Vazin
Journal:  Ther Adv Drug Saf       Date:  2020-12-28

5.  Characteristics and lessons learned from practice-based research networks (PBRNs) in the United States.

Authors:  Melinda M Davis; Sara Keller; Jennifer E DeVoe; Deborah J Cohen
Journal:  J Healthc Leadersh       Date:  2012-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.